91 results on '"Celada A"'
Search Results
2. PO-1071 Oxygen therapy at 1.4 atmospheres in radiation-induced cystitis and proctitis
3. PO-1605 LATTICE radiotherapy: A one institution experience
4. PO-1811 Efficacy of Episcleral Brachytherapy in Choroidal Melanoma
5. PO-1349 Consensus radiotherapy guidelines vulvar cancer: Spanish GINECOR / SEOR group modified Delphi study
6. PO-1468 LATTICE radiotherapy: A one institution experience
7. PO-1349 Consensus radiotherapy guidelines vulvar cancer: Spanish GINECOR / SEOR group modified Delphi study
8. PO-1468 LATTICE radiotherapy: A one institution experience
9. PO-1811 Efficacy of Episcleral Brachytherapy in Choroidal Melanoma
10. PD-0866 100% Peer Review in Radiation Oncology. Is it feasible?
11. PD-0866 100% Peer Review in Radiation Oncology. Is it feasible?
12. PO-0225 Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy
13. PO-0206 A dosimetric index to assess cervix brachytherapy implants: Dovix
14. PO-0206 A dosimetric index to assess cervix brachytherapy implants: Dovix
15. PO-1323 Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
16. PO-1497: Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement.
17. PO-1496: Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments
18. PO-1290: 100% peer review in radiation oncology. Is it feasible?
19. PO-0225 Automatic reporting of vaginal dose points for cervical cancer HDR-brachytherapy
20. PO-1290: 100% peer review in radiation oncology. Is it feasible?
21. PO-1496: Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments
22. PO-1497: Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement
23. EP-1220: Use of VMAT in Linac-SRS Vestibular Schwannomas. Dosimetric report of 34 cases in our Institution
24. EP-1220: Use of VMAT in Linac-SRS Vestibular Schwannomas. Dosimetric report of 34 cases in our Institution
25. EP-2008: Robustness of the OARs recommendations made by GEC-ESTRO according to inter-observer variability
26. PO-0726: Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
27. PO-0726: Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
28. Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
29. PO-0723: Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
30. PV-0035: Electronic brachytherapy for basal cell carcinoma: two prospective pilot trials with different doses
31. EP-2008: Robustness of the OARs recommendations made by GEC-ESTRO according to inter-observer variability
32. PO-0959: Dosimetric outcome and perioperative toxicity using Utrecht applicator in cervical brachytherapy
33. EP-1234: VMAT based lung ablative radiotherapy: primary lesions and metastases
34. EP-1613: Depth determination of skin cancers treated with superficial barchytherapy: ultrasound vs. histopathology
35. EP-1590: Shielding design and fetal dose evaluation of a breast cancer pregnant patient undergoing HDR Ir-192 brachytherapy
36. PO-0978: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
37. EP-1613: Depth determination of skin cancers treated with superficial barchytherapy: ultrasound vs. histopathology
38. Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
39. EP-1590: Shielding design and fetal dose evaluation of a breast cancer pregnant patient undergoing HDR Ir-192 brachytherapy
40. PO-0723: Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
41. EP-1256: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
42. EP-1256: Salvage iodine-125 brachytherapy for local prostate cancer recurrence after radiotherapy
43. EP-1948: Keloids treatment brachytherapy
44. EP-1897: Clinical outcomes and toxicity in MRI based cervical brachytherapy
45. PO-0983: High dose rate hypofractionated in skin cancer using the Valencia applicator
46. EP-1897: Clinical outcomes and toxicity in MRI based cervical brachytherapy
47. EP-1948: Keloids treatment brachytherapy
48. PO-0983: High dose rate hypofractionated in skin cancer using the Valencia applicator
49. PO-220 DOSE ESCALATION TO 160 GY IN I-125 PROSTATE IMPLANTS. EARLY CLINICAL RESULTS
50. PO-291 UTRECHT INTERSTITIAL CT/MRI APPLICATOR FOR MRI IMAGING GUIDED HDR-BRACHYTHERAPY: DOSE VOLUME ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.